Flow Diverters Market Report 2026

Flow Diverters Market Overview

• Flow Diverters market size has reached to $0.55 billion in 2025 • Expected to grow to $0.95 billion in 2030 at a compound annual growth rate (CAGR) of 11.4% • Growth Driver: Surge In Aneurysms Fueling The Growth Of The Flow Diverters Market Due To Aging Population And Advancements In Diagnostics • Market Trend: Innovative Hybrid Polymer-Metal Flow Diverters Set New Standard For Brain Aneurysm Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Flow Diverters Market?

Flow diverters are specialized endovascular devices used to treat intracranial aneurysms, particularly large or complex ones. They are tubular, mesh-like stents placed within the parent blood vessel to divert blood flow away from the aneurysm sac. This redirection promotes thrombosis within the aneurysm while preserving normal circulation in surrounding vessels. Flow diverters represent a minimally invasive alternative to surgical clipping or coiling. The main types of flow diverters include pipeline embolization devices, silk flow diverters, surpass flow diverters, flow redirection endoluminal devices, and others. Pipeline embolization devices refer to minimally invasive, stent-like implants used to treat brain aneurysms by diverting blood flow away from the aneurysm sac, promoting vessel wall healing. These are made from various materials such as nitinol, cobalt-chromium alloy, stainless steel, and others, and find applications in intracranial aneurysms, arteriovenous malformations, carotid artery disease, and others, serving end-uses in hospitals and clinics and ambulatory surgical centers.

What Is The Flow Diverters Market Growth Forecast?

The flow diverters market size is expected to see rapid growth in the next few years. It will grow to $0.95 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to development of next-generation flow diverters with enhanced flexibility, rising demand for minimally invasive neurovascular procedures, growing investment in hospital endovascular infrastructure, increasing regulatory approvals for new devices, integration of imaging and AI-assisted deployment technologies. Major trends in the forecast period include rising adoption of minimally invasive neurovascular procedures, increasing use of flow diverters in complex aneurysms, development of advanced nitinol and cobalt-chromium devices, expansion of endovascular treatment centers, focus on reducing procedure complications and enhancing patient safety.

Global Flow Diverters Market Segmentation

1) By Type: Pipeline Embolization Device, Silk Flow Diverter, Surpass Flow Diverter, Flow Redirection Endoluminal Device, Other Types 2) By Material: Nitinol, Cobalt-Chromium Alloy, Stainless Steel, Other Materials 3) By Application: Intracranial Aneurysms, Arteriovenous Malformations, Complex Wide-Neck Aneurysms, Other Applications 4) By End-User: Hospital And Clinics, Ambulatory Surgical Centre Subsegments: 1) By Pipeline Embolization Device: Classic Pipeline Embolization Device, Pipeline Flex Embolization Device, Pipeline Shield Technology 2) By Silk Flow Diverter: Silk+ Flow Diverter, Silk Vista Baby 3) By Surpass Flow Diverter: Surpass Streamline, Surpass Evolve 4) By Flow Redirection Endoluminal Device: FRED Jr., FRED X 5) By Other Types: DERIVO Embolization Device, p64 Flow Modulation Device, Tubridge Flow Diverter

What Is The Driver Of The Flow Diverters Market?

The rising prevalence of aneurysms is expected to propel the growth of the flow diverters market going forward. Aneurysms refer to abnormal bulges or ballooning in the wall of a blood vessel, typically caused by weakening of the vessel wall. The increase in prevalence of aneurysms is driven by a rising aging population and improved diagnostic technologies, as they lead to higher detection rates and greater awareness, thereby increasing the number of diagnosed cases. Flow diverters help address the rising prevalence of aneurysms by redirecting blood flow away from the weakened vessel area, promoting healing, reducing the risk of rupture, and offering a minimally invasive alternative to traditional surgical treatments. For instance, in November 2025, according to the PubMed, a U.S.-based biomedical literature database or search engine, it was reported that about 3% of adults have an unruptured intracranial aneurysm, and this prevalence can increase to 10% in high-risk groups. Therefore, the rising prevalence of aneurysms is driving the growth of the flow diverters industry.

Key Players In The Global Flow Diverters Market

Major companies operating in the flow diverters market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Terumo Corporation, MicroPort Scientific Corporation, Penumbra Inc., Phenox GmbH, Sino Medical Sciences Technology Inc., Balt Extrusion S.A.S., Sequent Medical Inc., Wallaby Medical Ltd., Zylox Tonbridge Medical Technology Co. Ltd., Acandis GmbH & Co. KG, Fluid Biomed Inc., Oxford Endovascular Ltd., EndoStream Medical Ltd., Rapid Medical Ltd., Cerus Endovascular Ltd., NeuroVasc Technologies Inc., Shape Memory Medical Inc., Vesalio LLC

Global Flow Diverters Market Trends and Insights

Major companies operating in the flow diverters market are focusing on advancements in material science, such as polymer-based neurovascular stents, to enhance device performance, improve biocompatibility, promote natural vessel healing, and reduce the need for long-term blood-thinning medication. A polymer-based neurovascular stent is a medical implant designed to support and maintain the patency of blood vessels in the brain (neurovasculature), particularly in the treatment of conditions such as aneurysms, stenosis, or vascular malformations. For instance, in June 2023, Fluid Biomed, a Canada-based medical device start-up, announced the world’s first implantation of a polymer-based neurovascular stent in human patients. This innovative device, known as the ReSolv stent, is specifically designed to treat brain aneurysms. Unlike traditional hybrid polymer-metal stents, the ReSolv stent is entirely polymer-based and is engineered to gradually dissolve as the blood vessel heals. This unique design has the potential to minimize the need for long-term blood-thinning medication while supporting the natural healing process of the vessel.

What Are Latest Mergers And Acquisitions In The Flow Diverters Market?

In May 2023, Stryker Corporation, a US-based medical technology company, acquired Cerus Endovascular Ltd. for an undisclosed amount. Through this acquisition, Stryker enhances its Neurovascular division by integrating Cerus Endovascular’s innovative intrasaccular aneurysm treatment devices, expanding its hemorrhagic portfolio, strengthening its leadership in minimally invasive stroke care, and enabling physicians to treat a broader range of intracranial aneurysms with advanced, differentiated solutions. Cerus Endovascular Ltd. is a UK-based biotechnology company that designs and develops interventional neuroradiology devices and delivery systems.

Regional Outlook

North America was the largest region in the flow diverters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Flow Diverters Market?

The flow diverters market consists of revenues earned by entities providing services such as training and certification programs, research and clinical trials services, and reimbursement and insurance support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The flow diverters market also includes sales of low-profile flow diverters, variable porosity flow diverters, and expandable hybrid devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.